Minimum steroid dose added to incision anesthesia to reduce pain after spine surgery
Official title: Minimum Effective Dose of Incisional Local Infiltration Betamethasone for the Prevention of Pain After Spinal Surgery: a Randomised Controlled Trial
Run by Beijing Tiantan Hospital · NCT06785350 · Data updated 2026-11-12
This trial tests whether adding different low doses of betamethasone to ropivacaine injected into the incision reduces pain after spine surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 535 (estimated) |
| Sponsor | Beijing Tiantan Hospital Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | January 25, 2025 |
| Main results expected | September 1, 2025 |
| Study ends | December 1, 2025 |
| Registry record updated | July 16, 2025 |
| Trial ID | NCT06785350 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–65 years old with ASA physical status I–II scheduled for cervical, thoracic, or lumbar spine surgery of up to three levels who can give informed consent are the intended participants.
✕Probably not a fit
Patients with prior spinal surgery, peri-incisional infection, diabetes or other metabolic disorders, significant liver or kidney dysfunction, current systemic steroid use, pregnancy or breastfeeding, extreme BMI, serious neurologic or psychiatric disease, or substance abuse are unlikely to be eligible or to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults aged 18–65 undergoing cervical, thoracic, or lumbar spine surgery (up to three levels) at Beijing Tiantan Hospital will receive local infiltration of the surgical incision with one of five regimens: 0.5% ropivacaine alone or ropivacaine combined with betamethasone (Diprospan) at 0.012%, 0.009%, 0.006%, or 0.003%. The study compares postoperative incisional pain and related outcomes to identify the minimum effective concentration of betamethasone when used with local anesthetic. Standard perioperative care is provided and patients with significant comorbidities or contraindications are excluded. Results aim to guide dosing to minimize pain and opioid requirements after spine surgery.
Why it matters
Potential benefit: If successful, patients could have less incision pain after spine surgery, shorter recovery, and lower opioid use.
How similar studies have gone: Previous reports of local infiltration combining anti-inflammatory drugs with local anesthetic have reduced postoperative pain, but the optimal steroid concentration for spinal incision infiltration remains unestablished.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients scheduled for spine surgery under general anesthesia. Anticipated cervical, thoracic, and lumbar spine surgeries (within three level). Patients age 18-65 years. American Society of Anaesthesiologists Classification of I or II. Exclusion Criteria: Patients refuse to participate. Patients who are allergic to ropivacaine, betamethasone and opioid, . Pateints who have been abusing drugs or alcohol. Patients who have abnormalities in kidney or liver function tests. BMI\<15kg/m2 or\>35 kg/m2. Patient has a history of spinal surgery. Patient has peri-incisional infection. Patient has a history of stroke or other serious neurological disease. Patient has a history of diabetes and other metabolic disorders. Patient has a history of psychological disorders. Patient is on systemic steroids. Patient is pregnant or breastfeeding. Glasgow Coma Scale score \< 15 before surgery. Unable to provide written informed consent. Withdrawal criteria: Voluntary withdrawal. Delayed extubation. Poor cognitive function within 48 hours after surgery. Postoperative radiation therapy or chemotherapy during follow-up. Postoperative diagnosis of spinal cord or nerve root injury resulting in pain during follow-up. Reoperation during follow-up.
Where it's running
-
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dexmedetomidine as add-on for refractory cancer pain in palliative care
This study tests whether adding dexmedetomidine helps improve pain control for adults with cancer in palliative care whose pain remains high despite opioids.
-
Two Ways to Help Pain After Breast Surgery: Education-Based Analgesia vs Standard Care
This trial tests whether teaching patients about pain management and using a multimodal pain plan improves pain control and recovery after breast surgery compared with standard care.
-
Virtual Reality Therapy to Improve Arthroplasty Outcomes
This pilot test checks whether using virtual reality during the perioperative period helps knee or hip replacement patients feel better about their care and recover more easily.
-
Suzetrigine for pain relief after knee replacement
This trial tests whether suzetrigine can reduce opioid use after a total knee replacement compared with placebo.
-
Analgesic effects of adding BiFeS block to adductor canal block after ACL reconstruction
This study tests whether adding a BiFeS block to the standard adductor canal block provides better pain relief after ACL reconstruction.
-
Tegileridine for pain after bariatric surgery
This phase 3 trial tests tegileridine vs standard opioid medicine to see if it provides good pain relief after bariatric surgery while considering sleep apnea status.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.